Related references
Note: Only part of the references are listed.Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Anoop P. Patel et al.
LANCET NEUROLOGY (2019)
Simvastatin Sensitizes Radioresistant Prostate Cancer Cells by Compromising DNA Double-Strand Break Repair
Yu-An Chen et al.
FRONTIERS IN PHARMACOLOGY (2018)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2018)
Use of statins or NSAIDs and survival of patients with high-grade glioma
Corinna Seliger et al.
PLOS ONE (2018)
Outcome of patients with glioblastoma in Saudi Arabia: Single center experience
Abdullah K. Altwairgi et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
Statins are potential anticancerous agents (Review)
Abdullah K. Altwairgi
ONCOLOGY REPORTS (2015)
Statin use and survival following glioblastoma multiforme
David Gaist et al.
CANCER EPIDEMIOLOGY (2014)
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Patrizia Gazzerro et al.
PHARMACOLOGICAL REVIEWS (2012)
Lipid lowering efficacy of atorvastatin
Stephen P. Adams et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Atorvastatin: safety and tolerability
Vasilios G. Athyros et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Comparative safety of Atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients
C Newman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Statins of different brain penetrability differentially affect CSFPLTP activity
Simona Vuletic et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
